Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells - Chieng-Yane, P; Bocquet, A; Létienne, R (J Pharmacol Exp Ther, 2011)